# EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection

> **NCT02689518** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 50 (actual)

## Conditions studied

- Macular Degeneration
- Wet Macular Degeneration

## Interventions

- **DRUG:** Intravitreal aflibercept injection

## Key facts

- **NCT ID:** NCT02689518
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2019-11-12
- **Final completion:** 2019-11-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02689518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02689518, "EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02689518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*